Ignite Creation Date:
2024-05-05 @ 4:51 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00324220
Status:
COMPLETED
Last Update Posted:
2015-07-01
First Post:
2006-05-08
Brief Title:
A Phase III Study of MGCD0103 With Azacitidine in Patients With High-Risk Myelodysplastic Syndrome MDS or Acute Myelogenous Leukemia
Sponsor:
Mirati Therapeutics Inc
Organization:
Mirati Therapeutics Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Acute Myelogenous Leukemia |
| Myelodysplastic Syndrome |
Keywords:
| Name | View |
|---|---|
| Phase III | View |